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A B S T R A C T
Cardiac surgery (CS) with cardiopulmonary bypass (CPB) induces systemic inflammatory response by activating
plasma proteins and blood cells. Activated monocytes/macrophages produce inflammatory marker neopterin (NP). The
aim was to explore the NP kinetics in first 24 hours after CS according to the CPB use. Significant difference between
groups was found for NP levels 12 and 24 hrs after CS, being higher in on-pump group. Strong association was found
between NP levels 12 hrs after CS and the length of ICU stay for on-pump group (r=0.744, p<0.001). Strong association
was found between preoperative NP levels and the length of ICU stay for those on-pump patients with elevated preopera-
tive NP (r=0.855, p=0.001; linear regression equation y=0.50x – 5.14, p<0.001). Preoperative NP levels higher than 10
nmol/L in on-pump group could predict prolonged ICU stay and outpoint patients at higher risk for developing postoper-
ative complications and, therefore, help to determine the necessary therapeutic interventions.
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Introduction
Cardiac surgery with cardiopulmonary bypass (CPB)
induces systemic inflammatory response (SIR) by acti-
vating plasma proteins (complement, coagulation, and
fibrinolysis) and blood cells (neutrophils, monocytes/
macrophages, and lymphocytes). In uncomplicated cases,
SIR is temporary event representing a physiologic reac-
tion to tissue injury. However, if this response is exagger-
ated, it may lead to substantial morbidity, including myo-
cardial dysfunction, respiratory failure, renal and neu-
rological dysfunction, bleeding disorders, altered liver
function, and, ultimately, increased mortality1.
Activated monocytes/macrophages produce various
inflammatory markers including neopterin (NP), a pteri-
dine derivate synthesized from guanosine triphosphate2.
Its production is mainly induced by interferon-gamma
from T lymphocytes and co-stimulated by both TNF-al-
pha and endotoxins3. NP levels rise in the early stage of
different diseases and increased levels are usually in cor-
relation with severity of the disease4. Therefore, measur-
ing NP levels is helpful for follow-up pathological states
associated with the activation of cell-mediated immu-
nity5.
Dynamics of NP after cardiac surgery with the use of
CPB has been analyzed by Adamik and his co-workers.
They reported levels of NP at 24 and 48 hours after sur-
gery, along with procalcitonin, to be good predictor of
mortality of sepsis and postoperative complications sec-
ondary to CPB6. However, kinetics of NP within the first
24 hours is unknown.
Therefore, the main focus of this study was to explore
the NP kinetics in first 24 hours after cardiac surgery ac-
cording to the use of CPB. The secondary aim of this
study was to test hypothesis that NP, as a marker of acti-
vated monocytes/macrophages, can be used as an impor-
tant factor for monitoring patient's postoperative status.
Materials and Methods
Patients
Between April and December 2002, seventy eight con-
secutive patients undergoing elective cardiac surgery
were enrolled in the study and divided in two groups ac-
cording to the type of surgical procedure performed: 42
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patients undergoing cardiac surgery without the use of
CPB (off-pump group) and 36 patients undergoing car-
diac surgery with the use of CPB (on-pump group): 25
patients undergoing coronary artery bypass surgery, 4
patients undergoing aortal valve replacement and 7 pa-
tients undergoing mitral valve replacement. Patients un-
dergoing reoperations, combined procedures or emer-
gency surgery, those with acute or chronic renal failure
requiring hemodialysis and known inflammatory dis-
eases requiring antibiotics or steroids were not included.
Preoperative patient's characteristics are presented in
Table 1 while their intraoperative characteristics and
both length of ICU stay and total length of hospital stay
are presented in Table 2.
The Hospital ethics committee approved the study,
and informed written consent was obtained from each
patient.
Intraoperative patient management
Same anesthesia protocol was used for all patients. In
the on-pump group, just prior to establishing the cardio-
pulmonary bypass, patients were heparinized with 3 mg/kg
of heparin (Belupo, Koprivnica, Croatia), to achieve an acti-
vated coagulation time higher than 480 seconds. CPB was
performed with a membrane oxygenator and roller pump
system. Details of the extracorporeal circulation and perfu-
sion procedures have been published previously7. After dis-
continuation of CPB, heparin was neutralized with pro-
tamine sulphate (ICN, Budapest, Hungary).
In the off-pump group, patients were heparinized
with 1 mg/kg. Myocardial stabilization was achieved us-
ing the vacuum stabilizers (Octopuss; Starfish-Medtro-
nic, Inc., Minneapolis (MN), USA). Details on surgical
procedure have been published previously8. After all ana-
stomoses were completed, heparin was fully reversed
with protamine sulphate.
Blood sampling
Blood samples were taken from each patient at four
predefined time points. First blood sample was taken be-
tween 6 and 8 am one day before the surgery. Next sam-
ples were drawn 12 and 24 hours after the surgery. The
last sample was obtained on third postoperative day be-
tween 6 and 8 am. Blood samples were drawn from pe-
ripheral venous line (BD Vacutainer System; Becton,
Dickinson & Co., Plymouth, UK). After withdrawal,
blood was spun down for 15 minutes (3000g at 4 °C) and
serum was stored at –86 °C until it was assayed.
Neopterin measurements
The serum NP concentrations were measured by
commercial ELISA kit (Quantikine; R&D Systems, Vi-
enna, Austria) in duplicate. According to the manufactu-
rer's information, sensitivity of the assay was 10 nmol/L.
The intra-assay variability coefficients were 1.1–3.1%,
while the inter-assay variability coefficients were 5.6–
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TABLE 1
BASIC CLINICAL CHARACTERISTICS OF PATIENTS WHO UNDERWENT ELECTIVE CARDIAC SURGERY WITH (ON-PUMP) OR WITHOUT
(OFF-PUMP) THE USE OF CARDIOPULMONARY BYPASS
Off-pump On-pump p value*
Number of patients 42 36 –
Male sex, n (%) 32 (76) 25 (69) 0.679
Age, years (median, range) 59 (56–66) 65 (62–68) 0.140
Diabetes mellitus, n (%) 12 (29) 20 (56) 0.028
Arterial hypertension, n (%) 29 (69) 16 (44) 0.050
Hyperlipidemia, n (%) 23 (55) 10 (28) 0.029
EuroScore (median, range) 2 (0–12) 3 (0–7) 0.899
Myocardial infarction, n (%) 23 (55) 11 (31) 0.055
Cerebrovascular insult, n (%) 1 (2) 1 (3) 0.543
* Student’s t-test
TABLE 2
OPERATIVE CHARACTERISTICS OF PATIENTS WHO UNDERWENT ELECTIVE CARDIAC SURGERY WITH (ON-PUMP) OR WITHOUT
(OFF-PUMP) THE USE OF CARDIOPULMONARY BYPASS
Off-pump (n=42) On-pump (n=36) p value*
Total operating time (min) 200 (90–370) 200 (105–360) 0.966
Cardiopulmonary bypass time (min) – 72 (18–178) –
Aortic cross clamp time (min) – 45 (0–106) –
The length of stay at Intensive care unit (days) 2 (1–6) 2 (1–12) 0.145
Total hospital stay (days) 15 (6–44) 16 (6–29) 0.670
*Student’s t-test, variables are presented as median with range
6.1%. The investigator performing the assay was blinded
to all clinical data and outcomes.
Statistical analysis
Data were summarized using proportions, median
and range, and mean and standard deviation, as indi-
cated. The associations between variables were assessed
by Pearson’s r, while the predictions were made on the
basis of linear regression analysis. The neopterin dynam-
ics were first analyzed by repeated-measures ANOVA,
followed by either independent-samples or paired-sam-
ples Student’s t-test with Bonferroni’s correction for
multiple testing. The alpha level was set at 0.05. All the
analyses were performed using SPSS 13 for Windows
(SPSS Inc., Chicago, IL).
Results
Preoperative NP concentrations were age dependent,
being higher in elderly people (r=0.396, p<0.001), but
not gender-related. Significantly more patients in the
on-pump group had diabetes mellitus, while in off-pump
group more patients had hyperlipidemia (Table 1). How-
ever, no association was found between preoperative NP
values and any of the preoperative characteristics (data
not shown). Furthermore, postoperative NP concentra-
tions were not associated with the operative characteris-
tics (data not shown).
The NP levels were significantly influenced by the
type of operation, being higher in the on-pump group
(ANOVA, F1,45=4.152, p=0.047). Specifically, significant
difference between the groups was found for concentra-
tions at 12 and 24 hours after the surgery (p<0.05) (Fig-
ure 1). To determine if NP kinetics after the surgery was
associated with preoperative NP values, Pearson correla-
tion coefficients were calculated. Good associations were
found between preoperative NP values and all postopera-
tive time points in both groups (Table 3).
Moderate correlation was found between preopera-
tive NP concentration and the length of ICU stay for
on-pump group (r=0.526, p=0.001) while no such associ-
ation was detected for off-pump group. NP concentra-
tions 12 hours after the surgery showed very good corre-
lation with the length of ICU stay for on-pump group
(r=0.744, p<0.001) while the correlation in the off-pump
group was slightly weaker (r=0.556, p=0.001). Further-
more, NP concentrations 24 hours after the surgery
showed poorer but significant associations for both
groups (r=0.455, p=0.010 for on-pump, and r=0.387,
p=0.016 for off-pump group). The linear regression anal-
ysis indicated that the length of ICU stay could be pre-
dicted by NP concentrations 12 hours after the surgery
(regression equation y=0.17x + 0.69, p<0.001), only for
the on-pump group.
Due to the wide range of preoperative NP levels in our
study (1.6–31.4 nmol/L), patients were additionally com-
pared on the basis of a cut-off value, set to 10 nmol/L, as a
generally accepted upper value of normal NP range4.
There were 7 patients (17%) in off-pump group and 12
patients (34%) in on-pump group with elevated preopera-
tive NP levels (Figure 2). Strong association was found
between preoperative NP levels and the length of ICU
stay only for on-pump patients with elevated preopera-
tive NP (r=0.855, p=0.001). The linear regression analy-
sis showed that the length of ICU stay could be predicted
by preoperative NP concentrations (regression equation
y = 0.50x – 5.14, p<0.001) in this subgroup of patients.
Discussion
Our study was the first to describe NP kinetics within
first 24 hours after cardiac surgery, with respect to the
use of CPB. Elevated postoperative NP levels were indi-
rectly related to the development of postoperative com-
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TABLE 3
ASSOCIATION OF PREOPERATIVE NEOPTERIN (NP) VALUES
WITH NP VALUES AT VARIOUS TIME POINTS AFTER THE
SURGERY IN PATIENTS WHO UNDERWENT ELECTIVE CARDIAC
SURGERY WITH (ON-PUMP) OR WITHOUT (OFF-PUMP) THE
USE OF CARDIOPULMONARY BYPASS
Preoperative NP value
NP values
after surgery
Off-pump (n=42) On-pump (n=36)
r* p r* p
12 hrs 0.572 0.001 0.670 <0.001
24 hrs 0.485 0.002 0.498 0.004
72 hrs 0.393 0.021 0.644 <0.001
*Pearson’s correlation coefficient
*
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Fig. 1. Neopterin kinetics (X±SD) in 78 patients who underwent
elective cardiac surgery with (on-pump) or without (off-pump)
the use of cardiopulmonary bypass. Circles – on-pump patients
(n=36), squares – off-pump patients (n=42). Asterisk indicates
p<0.05 for on-pump vs. off-pump group in the same time point,
Student’s t-test with Bonferroni’s correction.
plications by predicting prolonged ICU stay. Further-
more, preoperative NP cut-off value set at 10 nmol/L
could be used to predict the length of ICU stay after car-
diac surgery performed with the use of CPB.
Early postoperative NP kinetics was similar in both
on-pump and off-pump group, although absolute levels
were significantly higher in the on-pump group, particu-
larly at 12 and 24 hrs after the surgery (Figure 1).
Postoperative NP increase in the on-pump group could
present a cumulative consequence of both blood contact
with CPB tubes (which activated monocytes/macrophag-
es9,10) and surgical stress. This event indicates more acti-
vated cell-mediated immune response which suggest
progress of certain postoperative complications, probably
associated with infection. Slight NP increase in the off-
-pump group is a result of operative trauma per se, also
observed in the study of Johansson-Synnergren et al.11
and explained it as less inflammatory-associated compli-
cations in off-pump patients.
Examining the absolute numbers of preoperative NP
values, wide range was observed (1.6–31.4 nmol/L). There
are plenty of evidence that macrophages are activated in
diabetes mellitus, due to the chronic hyperglycemia12,13.
Since there were more patients in on-pump group with
diabetes mellitus, this could be one possible reason for el-
evated preoperative NP in this patient group. Further-
more, it was noticed that in atherosclerosis and its com-
plications (e.g. hyperlipidemia), NP was present in blood
as a result of macrophage activation14–16. This could in-
fluence on NP levels in off-pump patients since there was
higher incidence of hyperlipidemia. However, no associa-
tion between hyperlipidemia and diabetes mellitus with
preoperative NP levels was found in our study.
Since our primary hypothesis was that NP can be
used as a predictor of postoperative complications, after
failing to relate any specific complication to NP levels
(data not shown), we have analyzed the relationship be-
tween postoperative NP levels and the length of ICU
stay, as a non-specific and indirect factor reflecting pa-
tient’s status. Linear regression analyses have pointed
out that the length of ICU stay could be predict with NP
levels 12 hours after surgery only for patients in on-
pump group. Therefore, patients with elevated early
postoperative NP levels should be treated with extra at-
tention and monitoring, due to higher risk for developing
certain postoperative complications. Due to a small study
sample as well as different surgical procedures perfor-
med, exact postoperative complications that are associ-
ated with elevated NP still have to be determined.
Several studies have shown that using NP cut-off
value, set to 10 nmol/L, was useful method for detecting
normal and elevated concentrations4,17. After introduc-
tion of this cut-off level in our study, the shape of neo-
pterin kinetic cur
ve remain similar within groups. However, absolute
levels were higher for those patients with preoperative
NP values higher then 10 nmol/L. Elevated preoperative
NP levels remain significantly elevated postoperatively
till 12 hrs for on-pump group and 24 hrs for off-pump
group. This evidence showed us that even preoperative
elevated NP levels could identify patients at higher risk
for prolonged ICU stay.
Similar to the work of Adamik et al.6, our study points
out that NP is an important determinant of SIR. How-
ever, there were only few studies exploring the role of NP
after cardiac surgery6,10,18,19, probably due to the fact that
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Fig. 2. Neopterin (NP) kinetics (N ± SD) in patients who under-
went elective cardiac surgery with (on-pump, n=36) (a) or without
(off-pump, n=42) the use of cardiopulmonary bypass (b). Patients
were compared with respect to the NP cut-off value of 10 nmol/L
(represented with reference line): squares – patients with preoper-
ative NP values higher then 10 nmol/L, circles – patients with
preoperative neopterin values lower then 10 nmol/L. Asterisk indi-
cates p<0.05 for patients with preoperative NP levels higher then
10 nmol/L vs. patients with equal or lower NP levels in the same
time point, Student’s t-test with Bonferroni’s correction.
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NP was mainly considered to be a marker of sepsis20,21
and prognostic marker in malignant diseases22–24. Mea-
surement of NP values after cardiac surgery could be ad-
vocated by several arguments: first, the NP value not
only reflects the effect of a single cytokine but also allows
assessing the cumulative effect of immunological net-
work on the population of monocytes/macrophages25,
secondly, NP is inert and its biological half-life is only de-
termined by renal excretion, which is in contrast with
the biological half-life of cytokines that stimulate NP se-
cretion (i.e. interferon-gamma and TNF-alpha) influen-
ced by target and/or soluble receptors. Moreover, increa-
sed NP concentrations after cardiac surgery are probably
related to endothelial damage20, which is consistent with
recent findings of endothelial damage as a central fea-
ture in CPB related procedure26 that can be distingui-
shed from off-pump procedure.
Limitations of our study include small sample size
and wide age range (39–77 years). Since preoperative NP
levels were age dependent, it is necessary to analyze rela-
tionship between NP and the length of ICU stay in more
specifically designed patient groups. Additionally, this
study was not designed to study clinical endpoints and,
therefore, future studies are necessary to determine ex-
act postoperative complications associated with higher
preoperative NP levels.
In summary, our study describes NP kinetics early af-
ter cardiac surgery in respect of the use of CPB. CPB was
found to increase postoperative NP levels more than
off-pump surgery, especially in patients with higher NP
levels preoperatively. Preoperative NP levels higher than
10 nmol/L in on-pump group predicted prolonged ICU
stay and therefore, could outpoint patients at higher risk
for developing postoperative complications. This is im-
portant because the early identification of patients at
risk of developing postoperative complications may help
in determining therapeutic interventions.
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